tiprankstipranks
Aspen Pharmacare Holdings Limited (APNHF)
OTHER OTC:APNHF

Aspen Pharmacare Holdings (APNHF) Stock Price & Analysis

15 Followers

APNHF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$8.01 - $12.56
Previous Close$11.19
Volume1.00
Average Volume (3M)N/A
Market Cap
$4.97B
Enterprise Value$5.94B
Total Cash (Recent Filing)Rs8.04B
Total Debt (Recent Filing)Rs26.80B
Price to Earnings (P/E)18.8
Beta0.86
Sep 03, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.68%
Share Statistics
EPS (TTM)0.59
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.14
R-Squared0.18
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

APNHF FAQ

What was Aspen Pharmacare Holdings Limited’s price range in the past 12 months?
Aspen Pharmacare Holdings Limited lowest stock price was $8.01 and its highest was $12.56 in the past 12 months.
    What is Aspen Pharmacare Holdings Limited’s market cap?
    Currently, no data Available
    When is Aspen Pharmacare Holdings Limited’s upcoming earnings report date?
    Aspen Pharmacare Holdings Limited’s upcoming earnings report date is Sep 03, 2024 which is in 129 days.
      How were Aspen Pharmacare Holdings Limited’s earnings last quarter?
      Aspen Pharmacare Holdings Limited released its earnings results on Mar 04, 2024. The company reported $0.279 earnings per share for the quarter, beating the consensus estimate of N/A by $0.279.
        Is Aspen Pharmacare Holdings Limited overvalued?
        According to Wall Street analysts Aspen Pharmacare Holdings Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Aspen Pharmacare Holdings Limited pay dividends?
          Aspen Pharmacare Holdings Limited does not currently pay dividends.
          What is Aspen Pharmacare Holdings Limited’s EPS estimate?
          Aspen Pharmacare Holdings Limited’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Aspen Pharmacare Holdings Limited have?
          Aspen Pharmacare Holdings Limited has 446,252,320 shares outstanding.
            What happened to Aspen Pharmacare Holdings Limited’s price movement after its last earnings report?
            Aspen Pharmacare Holdings Limited reported an EPS of $0.279 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.565%.
              Which hedge fund is a major shareholder of Aspen Pharmacare Holdings Limited?
              Currently, no hedge funds are holding shares in APNHF
              ---

              Aspen Pharmacare Holdings Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Positive
              20 days / 200 days
              Momentum
              10.36%
              12-Months-Change

              Fundamentals

              Return on Equity
              5.80%
              Trailing 12-Months
              Asset Growth
              7.48%
              Trailing 12-Months

              Company Description

              Aspen Pharmacare Holdings Limited

              Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. It operates through the following segments: Therapeutic Focused Brands, Other Pharmaceuticals, and Nutritionals. The Therapeutic Focused Brands segment includes Anaesthetics and Thrombosis portfolios. The Nutritionals segment manufactures and markets in sub-Saharan Africa, Australia and Latin America. The company was founded by Michael Guy Attridge and Stephen Bradley Saad in 1850 and is headquartered in Durban, South Africa.
              ---

              APNHF Company Deck

              ---

              APNHF Earnings Call

              Q2 2024
              0:00 / 0:00
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Bristol-Myers Squibb
              Merck & Company
              Eli Lilly & Co
              GlaxoSmithKline
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis